Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;48(3):869-82.
doi: 10.4143/crt.2015.290. Epub 2016 Jan 21.

Incidence and Survival of Childhood Cancer in Korea

Affiliations
Free PMC article

Incidence and Survival of Childhood Cancer in Korea

Hyeon Jin Park et al. Cancer Res Treat. .
Free PMC article

Abstract

Purpose: An epidemiologic study of childhood cancer would provide useful information on cancer etiology and development of management guidelines.

Materials and methods: Data from the Korea National Cancer Incidence Database were used to examine the incidence and survival of cancer in patients aged 0-14 years. Patients were grouped according to the International Classification of Childhood Cancer, 3rd edition. Age-specific and age-standardized incidences per million and estimated annual percentage change (APC) were calculated by sex and age. Five-year relative survival was calculated for four periods from 1993 to 2011.

Results: The study comprised 15,113 patients with malignant neoplasms. Age-standardized incidence rates for all cancers were 134.9 per million children in 1999-2011 and 144.0 and 124.9 per million for males and females, respectively (M/F ratio, 1.2; p < 0.05). The highest incidences were observed for 'leukemias, myeloproliferative diseases, and myelodysplastic diseases' (group I) (46.4), 'central nervous system neoplasms' (group III) (18.3), and 'lymphomas and reticuloendothelial neoplasms' (group II) (13.4). Age-standardized incidence increased from 117.9 in 1999 to 155.3 in 2011, with an APC of 2.4% (95% confidence interval, 2.1 to 2.7). There was a significant increase of APC in 'neuroblastoma and other peripheral nervous cell tumors' (group IV) (5.6%) and 'other malignant epithelial neoplasms and malignant melanomas' (group XI) (5.6%). The 5-year relative survival rate for all childhood cancers improved significantly from 56.2% (1993-1995) to 78.2% (2007-2011) (males, 56.7% to 77.7%; females, 55.5% to 78.8%).

Conclusion: This study provides reliable information on incidence and survival trends for childhood cancer in Korea.

Keywords: Child; Incidence; Korea; Neoplasms; Survival.

Conflict of interest statement

Conflict of interest relevant to this article was not reported.

Figures

Fig. 1.
Fig. 1.
Cancer incidence by diagnostic groups in children (0-14 years of age) in Korea, 1999-2011. MPD, myeloproliferative diseases; MDD, myelodysplastic diseases; CNS, central nervous system.
Fig. 2.
Fig. 2.
Annual percent change of cancer incidence by diagnostic groups in children (0-14 years of age) in Korea, 1999-2011. MPD, myeloproliferative diseases; MDD, myelodysplastic diseases; CNS, central nervous system. *p < 0.05.
Fig. 3.
Fig. 3.
Trends in relative survivalrate (RSR) of childhood cancerin Korea according to age and the time period, 1993-2011. (A) Both sexes. (B) Male. (C) Female.

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

References

    1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41. - PubMed
    1. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004) Cancer. 2008;112:416–32. - PubMed
    1. Michel G, von der Weid NX, Zwahlen M, Redmond S, Strippoli MP, Kuehni CE, et al. Incidence of childhood cancer in Switzerland: the Swiss Childhood Cancer Registry. Pediatr Blood Cancer. 2008;50:46–51. - PubMed
    1. Baade PD, Youlden DR, Valery PC, Hassall T, Ward L, Green AC, et al. Trends in incidence of childhood cancer in Australia, 1983-2006. Br J Cancer. 2010;102:620–6. - PMC - PubMed
    1. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. - PMC - PubMed
Feedback